EMA's #safety committee, the #PRAC, has recommended withdrawal of marketing authorisations for amfepramone obesity drugs.

While evaluation of heavy menstrual bleeding cases with #COVID19 mRNA vaccines continues, no link found between these vaccines & absence of menstruation.

🐦🔗: https://nitter.eu/EMA_News/status/1535288570335870977